Subvenções e apoios para entidades sociais

Quantum-Testing Infrastructure for Quantum Technologies

União Europeia · EU

Quantum-Testing Infrastructure for Quantum Technologies

Período: 13 de agosto de 2026 – —

Superconducting Platform Technologies

União Europeia · EU

Superconducting Platform Technologies

Período: 13 de agosto de 2026 – —

Trapped-Ion Platform Technologies

União Europeia · EU

Trapped-Ion Platform Technologies

Período: 13 de agosto de 2026 – —

Ministero delle Infrastrutture e dei Trasporti - Incentivo Sea Modal Shift III annualità

Ministero delle infrastrutture e della mobilita' sostenibili · Nazionale

Quem pode candidatar-se Consorzio · Impresa

Cos'è Incentivo a favore dello schift modale del trasporto merci dalla strada alle rotte marittime. Le domande si presentano attraverso una piattaforma telematica accessibile sui siti del MIT e della società RAM Spa. A chi si rivolge L'incentivo è rivolto agli autotrasportatori. Cosa prevede L'incentivo è commisurato ai chilometri stradali evitati scegliendo di percorrere lo stesso tratto per via marittima.

Período: 18 de novembro de 2025 – —

Tribal Broadband Connectivity Program

Estados Unidos · US

Quem pode candidatar-se Others (see text field entitled "Additional Information on Eligibility" for clarification)

NTIA is soliciting applications for funds remaining under the Tribal Broadband Connectivity Program (TBCP), authorized by the Consolidated Appropriations Act, 2021, Division N, Title IX, Section 905(c), Public Law 116-260, 134 Stat. 1182 (Dec. 27, 2020) (Act), as amended by the Infrastructure Investment and Jobs Act, Division F, Title II, Section 60201, Public Law 117-58, 135 Stat. 429 (Nov. 15, 2021) (IIJA) (codified at 47 U.S.C. §1705). TBCP provides funding for grants to Eligible Entities to expand access to and adoption of: (i) broadband service on Tribal Land; or (ii) programs that promote remote learning, telework, or telehealth resources.

Native Entities Grant Program

Estados Unidos · US

Quem pode candidatar-se Others (see text field entitled "Additional Information on Eligibility" for clarification)

NTIA is soliciting applications for the Native Entities Grant Program (“Program”), authorized by the Infrastructure Investment and Jobs Act of 2021, Division F, Title III, Public Law 117-58, 135 Stat. 429, 1209 (November 15, 2021) (codified at 47 U.S.C. §1701, 1721, et seq.) (the “Digital Equity Act of 2021” or “Act”). The Act authorizes two programs that set aside funds for Indian Tribes, Alaska Native entities, and Native Hawaiian organizations (collectively “Native Entities”): the “State Digital Equity Capacity Grant Program” and the “Digital Equity Competitive Grant Program.” To reduce administrative burden and cost, NTIA is releasing the funds for both programs through a single application process.

National Science Foundation Translation to Practice

Estados Unidos · US

Quem pode candidatar-se Others (see text field entitled "Additional Information on Eligibility" for clarification)

The U.S. NSF Directorate for Technology, Innovation and Partnerships (NSF TIP) partners across sectors to advance three primary focus areas – accelerating technology translation and development, fostering regional innovation and economic growth, and preparing the American workforce for future high-wage jobs in STEM fields. The translation of research to practice ensures that the insights and innovations developed through scientific study and experimentation have tangible, positive impacts for the Nation. These impacts include improving the quality of life, promoting economic and job growth, ensuring national security, and maintaining global competitiveness. Indeed, scientific and engineering breakthroughs have the potential to address critical societal challenges in industries such as aerospace, agriculture, communications, education, energy, healthcare, national security, and transportation – but the translation of discoveries and innovations from the laboratory to society often takes many forms including non-linear pathways. The NSF TTP program was developed with several goals in mind: To identify and support use-inspired research and translational activities enabling a continuum from foundational research to practice; To develop partnerships and collaborations between institutions of higher education and other entities (e.g., industry, state/local/national government agencies, philanthropies, open-source ecosystems, for-benefit, for-profit and non-profit organizations, international organizations, etc.); To promote and advance the education and training of students and postdoctoral researchers, encouraging the participation of all Americans in STEM including innovation and entrepreneurship; and To identify future customer needs and opportunities and bring these to the forefront in the conduct of use-inspired research and translational activities. The NSF TTP program offers three tracks that represent different starting points or stages in moving discoveries and innovations from the laboratory to practice: NSF TTP-Explore (NSF TTP-E) is a pilot track that is likely to be the first step for researchers seeking to translate their basic research to practice. To be eligible for the NSF TTP-E track, proposers must have an active, eligible, NSF research award (see Eligibility Information for further details). TTP-E is designed to encourage current, eligible NSF awardees to intentionally pursue applications of their research with the potential for societal impact. The NSF TTP-E track provides the opportunity to obtain an extension of the initial award period of a current NSF award for up to two years in order to offer investigators an opportunity to explore adventurous, high-risk, use-inspired research and initial translational activities as the starting point for translation that was not covered by the original research award. NSF TTP-Translate (NSF TTP-T) starts with use-inspired research and initial translational activities and further matures the idea(s), iterates and improves the solution(s), and lowers the barrier(s) to effective translation of research from lab to practice. NSF TTP-Partner (NSF TTP-P) supports translational efforts that demand one or more partnerships for technology development and deployment. Here, strategic partnerships with stakeholders beyond U.S. institutions of higher education are essential ingredients for success and may include industry partners, government entities at all levels, philanthropies, international organizations, or other groups associated with large scale productization and distribution. The NSF TTP-P track requires an NSF-Catalyzed Partnership with an organization that will assist in the translation to practice. In addition to the Principal Investigator (PI), NSF TTP-P proposals must include a co-PI or Senior/Key Personnel who is a member or employee of the NSF-Catalyzed Partner. Partnerships with U.S. institutions of higher education are valued, but NSF TTP strongly prioritizes NSF-Catalyzed Partnerships that are able to help bring the product, process, or service to the market, potentially through licensing agreements, startup or small business formation, incorporation into an existing open-source ecosystem, development into standards setting arrangements, etc.

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Estados Unidos · US

Quem pode candidatar-se Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · Public housing authorities/Indian housing authorities · County governments · Independent school districts · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · City or township governments · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · State governments · Small businesses

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option).

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Estados Unidos · US

Quem pode candidatar-se Public and State controlled institutions of higher education · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · State governments · Small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high-priority research topics. This funding opportunity is intended to support feasibility clinical trials that provide new information that are scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent competitive full-scale clinical trial. Under this R34, the data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial, including, but not limited to the following: examining feasibility and acceptability of interventions lacking published data; tailoring or adapting the content or structure of an intervention to a specific population, modality, or setting; refining the intervention to determine the most appropriate frequency or duration; determining feasibility of recruitment, retention, and data collection procedures; refining and assessing the feasibility of protocolized multi-component interventions; or examining acceptability and adherence of control conditions. The subsequent full-scale clinical trial should have the potential to make a significant impact on public health. Prior to submitting to this NOFO, applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact person for the science area of the planned application.

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

Estados Unidos · US

Quem pode candidatar-se Native American tribal organizations (other than Federally recognized tribal governments) · For profit organizations other than small businesses · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Special district governments · Independent school districts · Public and State controlled institutions of higher education · State governments · City or township governments · Public housing authorities/Indian housing authorities

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH- designated areas of high research priority. Applications submitted under this NOFO are expected to propose a remotely delivered and conducted fully powered clinical trial with no in-person contact between research staff and study participants and may utilize mHealth tools or technologies. Applicants must provide justification for the remotely delivered approach and provide preliminary data on the feasibility and safety of the approach, along with evidence that the intervention has promise of clinical benefit. Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO.

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Estados Unidos · US

Quem pode candidatar-se For profit organizations other than small businesses · Independent school districts · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Special district governments · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Small businesses · County governments · City or township governments · Public housing authorities/Indian housing authorities · Native American tribal governments (Federally recognized) · Others (see text field entitled "Additional Information on Eligibility" for clarification)

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this NOFO are expected to propose a multisite feasibility clinical trial that will provide new information that is scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R01) research is scientifically necessary to design or plan the subsequent fully powered, full-scale clinical trial. Under this R01, the data collected should be used to fill gaps in scientific knowledge, including, but not limited to the following: assessing whether the intervention can be delivered with fidelity across sites; demonstrating feasibility of recruitment, accrual, and randomization of participants across sites; demonstrating participant adherence to the intervention, as well as retention of participants throughout the study across sites; refining and assessing the feasibility of protocolized multimodal interventions, and/or demonstrating feasibility of data collection across sites in preparation for a future fully powered, multisite efficacy or effectiveness trial. The need for multisite feasibility trials is expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s) or the published literature. The data collected should be used to fill gaps in scientific knowledge and be necessary to develop a competitive fully powered multisite clinical trial that has the potential to make a significant impact on public health.

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Estados Unidos · US

Quem pode candidatar-se Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Special district governments · Private institutions of higher education · State governments · For profit organizations other than small businesses · Public and State controlled institutions of higher education · City or township governments · County governments · Independent school districts · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

Call for proposals directed to civil society organisations for actions in Benin

União Europeia · EU

—

Período: 25 de setembro de 2026 – —

Driving Urban Transitions (DUT) Call 2026

União Europeia · EU

Cascade funding (FSTP – Financial Support to Third Parties). Driving Urban Transitions (DUT) Call 2026

Período: 1 de setembro de 2026 – —

CONVOCATORIA XXIX CERTAMEN DE BELENES MONCLOA ARAVACA 2026

LOCAL - MADRID - DISTRITO DE MONCLOA-ARAVACA ·

Quem pode candidatar-se PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Distrito de Moncloa-aravaca (Madrid). Convocatoria de concurrencia competitiva dirigida a personas físicas que no desarrollan actividad económica. Ámbito: administración pública y defensa; seguridad social obligatoria. Dotación de 1300 €. Plazo de solicitud hasta el 18/11/2026.

CONVOCATORIA XIX CERTAMEN VILLANCICOS MONCLOA-ARAVACA

LOCAL - MADRID - DISTRITO DE MONCLOA-ARAVACA ·

Quem pode candidatar-se PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Distrito de Moncloa-aravaca (Madrid). Convocatoria de concurrencia competitiva dirigida a personas físicas que no desarrollan actividad económica. Ámbito: administración pública y defensa; seguridad social obligatoria. Dotación de 1300 €. Plazo de solicitud hasta el 18/11/2026.

CONVOCATORIA XXXIII CERTAMEN DE DIBUJOS NAVIDEÑOS MONCLOA-ARAVACA 2026

LOCAL - MADRID - DISTRITO DE MONCLOA-ARAVACA ·

Quem pode candidatar-se PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Distrito de Moncloa-aravaca (Madrid). Convocatoria de concurrencia competitiva dirigida a personas físicas que no desarrollan actividad económica. Ámbito: administración pública y defensa; seguridad social obligatoria. Dotación de 1350 €.

Período: 24 de setembro de 2026 – —

CONVOCATORIA DEL CONCURSO PARA LA CREACIÓN DEL HIMNO DE TRES CANTOS CON MOTIVO DEL 35 ANIVERSARIO DE LA CIUDAD

LOCAL - TRES CANTOS - AYUNTAMIENTO DE TRES CANTOS ·

Quem pode candidatar-se PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Ayuntamiento de Tres Cantos (Comunidad de madrid). Convocatoria de concurrencia competitiva dirigida a personas físicas que no desarrollan actividad económica. Ámbito: actividades artísticas, deportivas y de entretenimiento. Dotación de 1500 €. Plazo de solicitud del 05/09/2026 al 18/11/2026.

Período: 5 de setembro de 2026 – —

PRIMERA CONVOCATORIA DEL PROGRAMA DE INCENTIVOS A PROYECTOS SINGULARES INNOVADORES DE AHORRO Y EFICIENCIA ENERGÉTICA (INNOVAE)

ESTADO - MINISTERIO PARA LA TRANSICIÓN ECOLÓGICA Y EL RETO DEMOGRÁFICO - INSTITUTO PARA LA DIVERSIFICACIÓN Y AHORRO DE LA ENERGÍA (IDAE) ·

Quem pode candidatar-se GRAN EMPRESA; PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA; PYME Y PERSONAS FÍSICAS QUE DESARROLLAN ACTIVIDAD ECONÓMICA

Industria y Energía

Período: 15 de setembro de 2026 – —

CCIAA Cuneo - Bando Reti d'impresa anno 2026 - cod. bando 2604

Camera di Commercio, Industria, Artigianato e Agricoltura di Cuneo · Piemonte

Quem pode candidatar-se Impresa

Cos'è Bando per la corresponsione di contributi a fondo perduto con l'obiettivo di favorire la costituzione, il consolidamento e la valorizzazione di Reti di impresa (ai sensi del DL 5/2009 convertito con modificazioni in Legge 33/2009, n. 33) al fine di accrescere la capacità innovativa e la competitività delle imprese. A chi si rivolge Il bando è rivolto a:- Reti soggetto: imprese riunite in reti regolarmente contrattualizzate, dotate di personalità giuridica e iscritte a Registro imprese. La rete deve avere sede in provincia di Cuneo - Reti contratto: imprese riunite in reti regolarmente contrattualizzate con iscrizione nella visura camerale di tutte le aziende retiste. La rete deve avere capofila e maggioranza delle imprese partecipanti con sede legale e/o unità operativa in provincia di Cuneo. Cosa prevede Spese ammissibili:- Spese per la costituzione di reti d’impresa costituite dalla data di apertura del bando (16/07/2026)- Spese per la gestione della comunicazione, promozione e valorizzazione di reti di impresa (realizzazione portale e sito internet, logo, campagne pubblicitarie, gadget promozionali) e relative traduzioni – sono ammesse solo le reti costituite dalla data di apertura del bando (16/07/2026)- Spese per la revisione sostanziale del contratto successive alla data di apertura del bando, per reti d’impresa già attivate a prescindere dalla data di costituzione- Spese per la formazione sulla gestione e sul management delle reti. Periodo di riferimento della realizzazione delle attività e delle spese (data emissione fattura): dalla data di apertura del bando 16/07/2026 fino al 31/05/2027. I progetti dovranno essere avviati e realizzati successivamente alla data di apertura del bando. Percentuale di contributo: 50% spese ammissibili al netto di Iva Importo minimo di spese sostenute: € 2.000,00Contributo massimo: € 5.000,00 + le premialità ammissibili fino ad un massimo di 2 premialità Premialità previste:- Rating di legalità - premialità pari a € 250,00- Certificazione parità di genere - premialità pari a € 250,00- Ubicazione al di sopra degli 800 m s.l.m. - premialità pari a € 500,00

Período: 16 de julho de 2026 – —

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Estados Unidos · US

Quem pode candidatar-se Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2. Distinctive Features: * This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance. * This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

DoW Breast Cancer, Clinical Research Extension Award

Estados Unidos · US

Quem pode candidatar-se Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

DARRP Restoration Implementation Grants (2026)

Estados Unidos · US

Quem pode candidatar-se Others (see text field entitled "Additional Information on Eligibility" for clarification)

The principal objective of the Damage Assessment, Remediation and Restoration Program (DARRP) Restoration Implementation Grants is for NOAA to collaborate with non-federal partners to implement marine and coastal habitat restoration and conservation in order to accomplish common goals related to oil spills, hazardous substance releases, and other natural resource damages. Successful applicants will support and implement restoration activities authorized under the Oil Pollution Act, Comprehensive Environmental Response, Compensation, and Liability Act, Clean Water Act, National Marine Sanctuaries Act, and other federal agencies' authorities related to oil spills, hazardous substance releases, and natural resource damages, such as the RESTORE Act. Notice of Funding Opportunity (NOFO) will be for those capable of implementing restoration and conservation activities across a wide geographic scale. NOAA NOFO Page 2 of 26 Restoration activities may include actions that rebuild productive and sustainable fisheries; contribute to the recovery and conservation of threatened and endangered species; and improve economic vitality, including local employment. Recipients will be implementing activities identified in consent decrees or natural resource damage assessment and restoration plans, and may be developing or soliciting projects to meet restoration goals. This may include recipients reviewing restoration plans and: collaborating with the trustee to select activities to be contracted or sub-awarded by the recipient; collaborating with the trustee to select projects for which the recipient has direct implementation responsibility; competition management to sub- award projects; and implementing pre- and post-restoration project evaluation and monitoring. Projects may also include restoration planning and technique development activities that further the mutual interests of DARRP and of funding recipient partners, such as environmental compliance analyses or restoration planning for potential, future incidents.

DOW Combat Readiness – Medical Research Program Translational Research Award

Estados Unidos · US

Quem pode candidatar-se Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-impact translational research that will accelerate the movement of promising ideas and/or technologies in trauma care into solutions to maximize casualty survivability, improve patient care closer to the point of injury and/or trauma care guidelines. Preliminary data are required. Research using well-validated animal models is allowed. Distinctive Features: • **NEW for FY26** An investigator may be named as the Principal Investigator (PI) on only one FY26 CRRP TRA application. • Research supported by the FY26 CRRP TRA must represent a mature, translational research effort with a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4.